| A population-based study of cardiovascular disease mortality risk in US cancer patients KM Sturgeon, L Deng, SM Bluethmann, S Zhou, DM Trifiletti, C Jiang, ... European heart journal 40 (48), 3889-3897, 2019 | 644 | 2019 |
| Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer Y Lu, J Xue, T Deng, X Zhou, K Yu, L Deng, M Huang, X Yi, M Liang, ... Nature medicine 26 (5), 732-740, 2020 | 433 | 2020 |
| Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization JH Stafford, T Hirai, L Deng, SB Chernikova, K Urata, BL West, JM Brown Neuro-oncology 18 (6), 797-806, 2016 | 191 | 2016 |
| Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non–small-cell … F Na, J Wang, C Li, L Deng, J Xue, Y Lu Journal of Thoracic Oncology 9 (6), 834-842, 2014 | 168 | 2014 |
| Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional … J Lan, R Li, LM Yin, L Deng, J Gui, BQ Chen, L Zhou, MB Meng, ... International Journal of Radiation Oncology* Biology* Physics 101 (1), 74-87, 2018 | 94 | 2018 |
| Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy EL Pollom, L Deng, RK Pai, JM Brown, A Giaccia, BW Loo Jr, DB Shultz, ... International Journal of Radiation Oncology* Biology* Physics 92 (3), 568-576, 2015 | 85 | 2015 |
| The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis L Yu, L Deng, J Li, Y Zhang, L Hu Gynecologic oncology 128 (2), 391-396, 2013 | 84 | 2013 |
| Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy MB Meng, HH Wang, YL Cui, ZQ Wu, YY Shi, NG Zaorsky, L Deng, ... Oncotarget 7 (35), 57391, 2016 | 75 | 2016 |
| Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy HH Wang, YL Cui, NG Zaorsky, J Lan, L Deng, XL Zeng, ZQ Wu, Z Tao, ... Cancer letters 375 (2), 349-359, 2016 | 75 | 2016 |
| Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer L Yin, J Xue, R Li, L Zhou, L Deng, L Chen, Y Zhang, Y Li, X Zhang, W Xiu, ... International Journal of Radiation Oncology* Biology* Physics 108 (1), 212-224, 2020 | 72 | 2020 |
| Pericytes: a double-edged sword in cancer therapy MB Meng, NG Zaorsky, L Deng, HH Wang, J Chao, LJ Zhao, ZY Yuan, ... Future oncology 11 (1), 169-179, 2015 | 70 | 2015 |
| Enhanced radioresponse with a novel recombinant human endostatin protein via tumor vasculature remodeling: experimental and clinical evidence MB Meng, XD Jiang, L Deng, FF Na, JZ He, JX Xue, WH Guo, QL Wen, ... Radiotherapy and Oncology 106 (1), 130-137, 2013 | 57 | 2013 |
| Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient with MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR … L Deng, LA Kiedrowski, E Ravera, H Cheng, B Halmos Journal of Thoracic Oncology 13 (9), e169-e172, 2018 | 50 | 2018 |
| SDF-1 blockade enhances anti-VEGF therapy of glioblastoma and can be monitored by MRI L Deng, JH Stafford, SC Liu, SB Chernikova, M Merchant, L Recht, ... Neoplasia 19 (1), 1-7, 2017 | 49 | 2017 |
| Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model J Lan, XL Wan, L Deng, JX Xue, LS Wang, MB Meng, H Ling, X Zhang, ... Radiation research 179 (4), 458-464, 2013 | 46 | 2013 |
| Association of PDCD1 and CTLA-4 gene expression with clinicopathological factors and survival in non–small-cell lung cancer: results from a large and pooled microarray database L Deng, B Gyorffy, F Na, B Chen, J Lan, J Xue, L Zhou, Y Lu Journal of Thoracic Oncology 10 (7), 1020-1026, 2015 | 42 | 2015 |
| Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer L Zhou, J Liu, J Xue, Y Xu, Y Gong, L Deng, S Wang, R Zhong, Z Ding, ... Radiation Oncology 9 (1), 1-9, 2014 | 38 | 2014 |
| Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002‐2018 C Jiang, L Deng, MA Karr, Y Wen, Q Wang, S Perimbeti, CL Shapiro, ... Cancer 128 (4), 828-838, 2022 | 35 | 2022 |
| The willingness and actual situation of Chinese cancer patients and their family members participating in medical decision‐making J Zhang, D Yang, Y Deng, Y Wang, L Deng, X Luo, W Zhong, J Liu, ... Psycho‐Oncology 24 (12), 1663-1669, 2015 | 32 | 2015 |
| Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer YL Wu, Q Zhao, L Deng, Y Zhang, XJ Zhou, YY Li, M Yu, L Zhou, BW Zou, ... Lung Cancer 127, 1-5, 2019 | 31 | 2019 |
